Literature DB >> 24279192

Parkinson disease in the elderly adult.

Allison W Willis1.   

Abstract

Parkinson disease is the second most neurodegenerative disease, after Alzheimer disease, that affects up to two million Americans, the overwhelming majority of whom are aged 60 and older. The changing demographics of the country place more Americans at risk for Parkinson disease (PD) than ever before. Primary care physicians treat the majority of PD patients in the United States. Here I review diagnosis and treatment strategies for idiopathic Parkinson disease in the elderly adult.

Entities:  

Mesh：

Year:  2013        PMID： 24279192      PMCID： PMC6179875     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  23 in total

1.  Mortality from Parkinson's disease.

Authors:  C E CLarke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

2.  Pesticide exposure and risk for Parkinson's disease.

Authors:  Alberto Ascherio; Honglei Chen; Marc G Weisskopf; Eilis O'Reilly; Marjorie L McCullough; Eugenia E Calle; Michael A Schwarzschild; Michael J Thun
Journal:  Ann Neurol       Date:  2006-08       Impact factor: 10.422

3.  Tai chi for patients with Parkinson's disease.

Authors:  Tao Liu; Lixing Lao
Journal:  N Engl J Med       Date:  2012-05-03       Impact factor: 91.245

4.  The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease.

Authors:  James Shearer; Colin Green; Carl E Counsell; John P Zajicek
Journal:  J Neurol       Date:  2011-08-05       Impact factor: 4.849

5.  Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease.

Authors:  Vladimir N Uversky; Jie Li; Kiowa Bower; Anthony L Fink
Journal:  Neurotoxicology       Date:  2002-10       Impact factor: 4.294

6.  Survival of Parkinson's disease patients in a large prospective cohort of male health professionals.

Authors:  Honglei Chen; Shumin M Zhang; Michael A Schwarzschild; Miguel A Hernán; Alberto Ascherio
Journal:  Mov Disord       Date:  2006-07       Impact factor: 10.338

7.  LRRK2 variation and Parkinson's disease in African Americans.

Authors:  Owen A Ross; Greggory J Wilhoite; Justin A Bacon; Alexandra Soto-Ortolaza; Jennifer Kachergus; Stephanie A Cobb; Andreas Puschmann; Carles Vilariño-Güell; Matthew J Farrer; Neill Graff-Radford; James F Meschia; Zbigniew K Wszolek
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

8.  Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries.

Authors:  Allison Wright Willis; Bradley A Evanoff; Min Lian; Susan R Criswell; Brad A Racette
Journal:  Neuroepidemiology       Date:  2010-01-15       Impact factor: 3.282

9.  Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease.

Authors:  Lisa M Shulman; Leslie I Katzel; Frederick M Ivey; John D Sorkin; Knachelle Favors; Karen E Anderson; Barbara A Smith; Stephen G Reich; William J Weiner; Richard F Macko
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

Review 10.  Gender differences in Parkinson's disease.

Authors:  Lisa M Shulman
Journal:  Gend Med       Date:  2007-03
View more
  7 in total

Review 1.  Potential neuroprotective activity of Ginseng in Parkinson's disease: a review.

Authors:  Elena González-Burgos; Carlos Fernandez-Moriano; M Pilar Gómez-Serranillos
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-29       Impact factor: 4.147

2.  Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons.

Authors:  Jay Prakash; Shikha Chouhan; Satyndra Kumar Yadav; Susan Westfall; Sachchida Nand Rai; Surya Pratap Singh
Journal:  Neurochem Res       Date:  2014-11-18       Impact factor: 3.996

Review 3.  Resting-state functional reorganization in Parkinson's disease: An activation likelihood estimation meta-analysis.

Authors:  Masoud Tahmasian; Simon B Eickhoff; Kathrin Giehl; Frank Schwartz; Damian M Herz; Alexander Drzezga; Thilo van Eimeren; Angela R Laird; Peter T Fox; Habibolah Khazaie; Mojtaba Zarei; Carsten Eggers; Claudia R Eickhoff
Journal:  Cortex       Date:  2017-04-08       Impact factor: 4.027

4.  Stochastic Epigenetic Mutations Influence Parkinson's Disease Risk, Progression, and Mortality.

Authors:  Gary K Chen; Qi Yan; Kimberly C Paul; Cynthia D J Kusters; Aline Duarte Folle; Melissa Furlong; Adrienne Keener; Jeff Bronstein; Steve Horvath; Beate Ritz
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

5.  Reversible Pharmacological Induction of Motor Symptoms in MPTP-Treated Mice at the Presymptomatic Stage of Parkinsonism: Potential Use for Early Diagnosis of Parkinson's Disease.

Authors:  Gulnara R Khakimova; Elena A Kozina; Valerian G Kucheryanu; Michael V Ugrumov
Journal:  Mol Neurobiol       Date:  2016-05-19       Impact factor: 5.590

6.  Neuroprotective Effects of Safflower Flavonoid Extract in 6-Hydroxydopamine-Induced Model of Parkinson's Disease May Be Related to its Anti-Inflammatory Action.

Authors:  Hui Lei; Rutong Ren; Yi Sun; Ke Zhang; Xin Zhao; Nuramatjan Ablat; Xiaoping Pu
Journal:  Molecules       Date:  2020-11-09       Impact factor: 4.411

7.  Antagonistic network signature of motor function in Parkinson's disease revealed by connectome-based predictive modeling.

Authors:  Xuyang Wang; Kwangsun Yoo; Huafu Chen; Ting Zou; Hongyu Wang; Qing Gao; Li Meng; Xiaofei Hu; Rong Li
Journal:  NPJ Parkinsons Dis       Date:  2022-04-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.